In this informative panel discussion, regulatory experts and representatives from Notified Bodies discuss how companies should respond to the proposed extended transition period and start implementing the new regulatory framework to meet the MDR’s robust requirements.
This session reviews the strategic questions R&D leaders must ask before every project and highlights how they should blend technology advancement with regulatory, payment and procedure changes in their portfolio decisions.
EU’s MDR, China’s Volume-Based Procurement Program and UK's Brexit have significant impacts on the go-to-market strategies of orthopedic companies.
Forecasting is critical for demand planning, managing inventory levels, manufacturing efficiency and many other core functions within orthopedic device companies and contract manufacturers. This session provides strategies that lead to more accurate forecasting and outlines essential techniques and tools to make informed decisions that improve your success rate.
Today’s orthopedic growth opportunities largely align with two strategies — responding to the shifts in care settings and adopting enabling and digital technology. The OMTEC keynote brings together diverse perspectives to provide insight into the significant changes shaping hospital and ASC decision-making, the enabling technology and digital tools that will prevail in orthopedics, and the new business models companies will assume and navigate in the next five years.
This presentation will answer questions repeatedly asked by orthopedic OEMs: Which AM platform technology — EMB or laser — is right for my product? Which laser platform — EOS, 3D Systems, GE Additive or another — is best? Which has the most FDA clearances, and what regulatory considerations do I need to consider relative to the processes?
Many orthopedic companies have prioritized commercializing solutions to combat antimicrobial resistance (AMR). CAM Bioceramics is designing and developing antimicrobial strategies based on calcium phosphates (CaPs) for hard and soft tissues. The company aims to research new technological solutions that prevent AMR.
Artificial Intelligence (AI) enhances the efficiency of dimensional inspections of orthopedic implants. This presentation will highlight the benefits of AI in the quality control process, including increased efficiency and the improved safety and performance of orthopedic implants.
Implantable orthopedic devices have an extensive history with gamma irradiation. This presentation will compare gamma to x-ray, describe similarities and differences, showcase the benefits of adding x-ray sterilization, and discuss considerations in validation and transfers from one radiation technology to another.
Computational Modeling & Simulation has the potential to revolutionize orthopedic device design and development. This presentation shares practical applications of the technology, how orthopedic companies can use it successfully and looks ahead to future applications of the tools.
Orthopedic manufacturers that take deep dives into data to run agile and resilient supply chains stay ahead of the competition — especially during uncertain times. This panel discussion outlines the benefits of leveraging technology to remain nimble in decision-making, better informed about managing inventory levels and prepared to proactively solve supply chain issues with hospital customers.
